ANDE HEALTHCARE: CSRC Requests Supplementary Explanations on Equity Pricing, Shareholding Nominee Arrangements and Dividend Rationality for H Share Listing

NewTimeSpace News: On 21 August 2026, the International Department of the China Securities Regulatory Commission (CSRC) released its Supplementary Filing Requirements for Overseas Listings (17 August to 21 August 2026), requesting Shandong Ande Healthcare Apparatus Co., Ltd. to provide supplementary explanations on specified matters regarding its filing for the H share listing, with clear legal opinions to be issued by lawyers after verification.

The CSRC asked the Company to clarify the pricing and pricing basis of each historical capital increase and share transfer, whether there were abnormal subscription prices or benefit transfers, whether capital contributions were fully paid up, and whether there were failures to fulfil capital contribution obligations, withdrawal of capital or defects in the form of capital contribution. It also requested concluding opinions on whether the Company's establishment and historical equity changes were lawful and compliant and whether any entities prohibited by laws and regulations from holding shares exist, as well as clarification of the pricing basis of the Company's share buybacks and the tax payment status of the parties whose shares were bought back.

The CSRC further required the Company to review its historical shareholding nominee arrangements in accordance with the relevant requirements under the Guidelines for Regulatory Rules–Overseas Issuance and Listing Category No. 2 and to issue a clear concluding opinion. The Company was also asked to explain the details of its earlier A share listing tutoring filing and the reasons for its withdrawal, the internal decision-making process for dividend payments during the reporting period and the fulfilment of regulatory procedures including tax payments, and to justify the rationality of the dividend payments with reference to the Company's liabilities and cash flows, as well as the necessity of the proposed listing and fund raising.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.